RMC-4998, CAS [[2642037-07-6]]

Artikelnummer: MCE-HY-156671
Artikelname: RMC-4998, CAS [[2642037-07-6]]
Artikelnummer: MCE-HY-156671
Hersteller Artikelnummer: HY-156671
Alternativnummer: MCE-HY-156671-5MG,MCE-HY-156671-10MMX1ML,MCE-HY-156671-10MG,MCE-HY-156671-50MG,MCE-HY-156671-25MG,MCE-HY-156671-100MG,MCE-HY-156671-1MG
Hersteller: MedchemExpress
Kategorie: Biochemikalien
RMC-4998 is an orally active inhibitor targeting the active or GTP-bound state of the KRASG12C mutant. RMC-4998 can form a ternary complex with intracellular CYPA and the activated KRASG12C mutant, with an IC50 value of 28 nM. RMC-4998 can inhibit ERK signaling in KRASG12C mutant cancer cells and induce apoptosis. RMC-4998 can be used for tumor research[1][2].
Molekulargewicht: 983.25
Reinheit: 99.31
CAS Nummer: [2642037-07-6]
Formel: C57H74N8O7
Target-Kategorie: Apoptosis,ERK,mTOR,PI3K,Ras
Anwendungsbeschreibung: Reference compound